Huang Z - Search Results

1

Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer.

Li H, Zhang Y, Xu Y, Huang Z, Cheng G, Xie M, Zhou Z, Yu Y, Xi W, Fan Y. Li H, et al. Among authors: huang z. Cell Death Dis. 2022 Dec 21;13(12):1064. doi: 10.1038/s41419-022-05510-4. Cell Death Dis. 2022. PMID: 36543792 Free PMC article.

2

[Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].

Fan Y, Huang ZY, Zhang YP, Sun L. Fan Y, et al. Ai Zheng. 2002 Dec;21(12):1368-71. Ai Zheng. 2002. PMID: 12520751 Clinical Trial. Chinese.

3

[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].

Fan Y, Huang ZY, Luo LH, Yu HF. Fan Y, et al. Ai Zheng. 2005 Dec;24(12):1503-6. Ai Zheng. 2005. PMID: 16351801 Chinese.

4

[Efficacy of GDP regimen (gemcitabine, dexamethasone, and cisplatin) on relapsed or refractory aggressive non-Hodgkin's Lymphoma: a report of 24 cases].

Fan Y, Huang ZY, Luo LH, Yu HF. Fan Y, et al. Ai Zheng. 2008 Nov;27(11):1222-5. Ai Zheng. 2008. PMID: 19000458 Free article. Chinese.

5

Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer.

Fan Y, Lin NM, Ma SL, Luo LH, Fang L, Huang ZY, Yu HF, Wu FQ. Fan Y, et al. Acta Pharmacol Sin. 2010 Jun;31(6):746-52. doi: 10.1038/aps.2010.50. Acta Pharmacol Sin. 2010. PMID: 20523345 Free PMC article. Clinical Trial.

6

[Efficacy of salvage chemotherapy in the advanced non-small cell lung cancer patients who failed the treatment of chemotherapy and EGFR-TKI].

Fan Y, Huang ZY, Yu HF, Luo LH. Fan Y, et al. Zhonghua Zhong Liu Za Zhi. 2010 Nov;32(11):859-63. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21223694 Clinical Trial. Chinese.

7

Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas.

Fan Y, Lin NM, Luo LH, Fang L, Huang ZY, Yu HF, Wu FQ. Fan Y, et al. Acta Pharmacol Sin. 2011 Mar;32(3):408-14. doi: 10.1038/aps.2010.217. Acta Pharmacol Sin. 2011. PMID: 21372831 Free PMC article.

8

[Phase II trial of improved regimen with gemcitabine in patients with advanced non-small cell lung cancer].

Miao L, Fan Y, Huang Z, Lin N, Luo L, Yu H. Miao L, et al. Among authors: huang z. Zhongguo Fei Ai Za Zhi. 2012 Jan;15(1):1-5. doi: 10.3779/j.issn.1009-3419.2012.01.01. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22237116 Free PMC article. Clinical Trial. Chinese.

9

Bevacizumab treatment for advanced non-small cell lung cancer: A case report.

Fan Y, Huang Z, Mao W. Fan Y, et al. Among authors: huang z. Oncol Lett. 2013 Dec;6(6):1779-1783. doi: 10.3892/ol.2013.1603. Epub 2013 Oct 4. Oncol Lett. 2013. PMID: 24260075 Free PMC article.

10

Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients.

Fan Y, Huang Z, Fang L, Miu L, Lin N, Gong L, Yu H, Yang H, Mao W. Fan Y, et al. Among authors: huang z. Onco Targets Ther. 2013 Dec 4;6:1789-803. doi: 10.2147/OTT.S52172. eCollection 2013. Onco Targets Ther. 2013. PMID: 24353431 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,757 results

Search Page

Filters